News
Alnylam Pharmaceuticals Halts Pursuit of sNDA for Patisiran
Alnylam Pharmaceuticals Inc. (ALNY) announced on Monday that it will no longer pursue its supplemental new drug application (sNDA) for patisiran as a ...
